U-Blot® Research Grade Anti-Human CD19 (GC019F)Cat. No. WA1360Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD19 (GC019F)Cat. No. WA1360
U-Blot® Research Grade Anti-Human CD19 (GC007g)Cat. No. WA1359
U-Blot® Research Grade Anti-Human CD19 (GBR 401)Cat. No. WA1358
U-Blot® Research Grade Anti-Human CD19 (DI-B4)Cat. No. WA1357
U-Blot® Research Grade Anti-Human CD19 (CYAD-04)Cat. No. WA1356
U-Blot® Research Grade Anti-Human CD19 (ALLO-501)Cat. No. WA1355
U-Blot® Research Grade Anti-Human CD19 & CD3E Bispecific Antibody (AMG 562)Cat. No. WA1354
U-Blot® Research Grade Anti-Human CD185/CXCR5 Antibody (PF-06835375)Cat. No. WA1353
U-Blot® Research Grade Anti-Human CD185/CXCR5 Antibody (HFB-100204)Cat. No. WA1352
U-Blot® Research Grade Anti-Human CD185/CXCR5 (HFB100204)Cat. No. WA1351
U-Blot® Research Grade Anti-Human CD185/CXCR5 (BAY-924)Cat. No. WA1350
U-Blot® Research Grade Anti-Human CD184/CXCR4 (PF-06747143)Cat. No. WA1349